These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

764 related articles for article (PubMed ID: 32845033)

  • 1. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2.
    Klemm T; Ebert G; Calleja DJ; Allison CC; Richardson LW; Bernardini JP; Lu BG; Kuchel NW; Grohmann C; Shibata Y; Gan ZY; Cooney JP; Doerflinger M; Au AE; Blackmore TR; van der Heden van Noort GJ; Geurink PP; Ovaa H; Newman J; Riboldi-Tunnicliffe A; Czabotar PE; Mitchell JP; Feltham R; Lechtenberg BC; Lowes KN; Dewson G; Pellegrini M; Lessene G; Komander D
    EMBO J; 2020 Sep; 39(18):e106275. PubMed ID: 32845033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery.
    Fu Z; Huang B; Tang J; Liu S; Liu M; Ye Y; Liu Z; Xiong Y; Zhu W; Cao D; Li J; Niu X; Zhou H; Zhao YJ; Zhang G; Huang H
    Nat Commun; 2021 Jan; 12(1):488. PubMed ID: 33473130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Native Mass Spectrometry Reveals Binding Interactions of SARS-CoV-2 PLpro with Inhibitors and Cellular Targets.
    James VK; Godula RN; Perez JM; Beckham JT; Butalewicz JP; Sipe SN; Huibregtse JM; Brodbelt JS
    ACS Infect Dis; 2024 Oct; 10(10):3597-3606. PubMed ID: 39303064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An
    Jamalan M; Barzegari E; Gholami-Borujeni F
    J Proteome Res; 2021 Jan; 20(1):1015-1026. PubMed ID: 33350309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.
    Báez-Santos YM; St John SE; Mesecar AD
    Antiviral Res; 2015 Mar; 115():21-38. PubMed ID: 25554382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating activity of SARS-CoV papain-like protease.
    Ratia K; Kilianski A; Baez-Santos YM; Baker SC; Mesecar A
    PLoS Pathog; 2014 May; 10(5):e1004113. PubMed ID: 24854014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
    Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
    ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-cov-2 PLpro.
    Liu X; Zheng M; Zhang H; Feng B; Li J; Zhang Y; Zhang J; Zhao N; Li C; Song N; Song B; Yang D; Chen J; Qi A; Zhao L; Luo C; Zang Y; Liu H; Li J; Zhang B; Zhou Y; Zheng J
    Antiviral Res; 2024 Aug; 228():105944. PubMed ID: 38914283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ISG15-Based High-Throughput Screening Assay for Identification and Characterization of SARS-CoV-2 Inhibitors Targeting Papain-like Protease.
    Samrat SK; Kumar P; Liu Y; Chen K; Lee H; Li Z; Chen Y; Li H
    Viruses; 2024 Aug; 16(8):. PubMed ID: 39205213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.
    Patchett S; Lv Z; Rut W; Békés M; Drag M; Olsen SK; Huang TT
    Cell Rep; 2021 Sep; 36(13):109754. PubMed ID: 34547223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel human USP2 inhibitor and its putative role in treatment of COVID-19 by inhibiting SARS-CoV-2 papain-like (PLpro) protease.
    Mirza MU; Ahmad S; Abdullah I; Froeyen M
    Comput Biol Chem; 2020 Dec; 89():107376. PubMed ID: 32979815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment.
    Stasiulewicz A; Maksymiuk AW; Nguyen ML; Bełza B; Sulkowska JI
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Covalent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): In Vitro and In Vivo Antiviral Activity.
    Velma GR; Shen Z; Holberg C; Fu J; Soleymani F; Cooper L; Ramos OL; Indukuri D; Musku SR; Rychetsky P; Slilaty S; Li Z; Ratia K; Rong L; Schenten D; Xiong R; J Thatcher GR
    J Med Chem; 2024 Aug; 67(16):13681-13702. PubMed ID: 39102360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors.
    Zhao Y; Du X; Duan Y; Pan X; Sun Y; You T; Han L; Jin Z; Shang W; Yu J; Guo H; Liu Q; Wu Y; Peng C; Wang J; Zhu C; Yang X; Yang K; Lei Y; Guddat LW; Xu W; Xiao G; Sun L; Zhang L; Rao Z; Yang H
    Protein Cell; 2021 Nov; 12(11):877-888. PubMed ID: 33864621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay.
    Narayanan A; Narwal M; Majowicz SA; Varricchio C; Toner SA; Ballatore C; Brancale A; Murakami KS; Jose J
    Commun Biol; 2022 Feb; 5(1):169. PubMed ID: 35217718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronaviral PLpro proteases and the immunomodulatory roles of conjugated versus free Interferon Stimulated Gene product-15 (ISG15).
    Gold IM; Reis N; Glaser F; Glickman MH
    Semin Cell Dev Biol; 2022 Dec; 132():16-26. PubMed ID: 35764457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease.
    Békés M; van der Heden van Noort GJ; Ekkebus R; Ovaa H; Huang TT; Lima CD
    Mol Cell; 2016 May; 62(4):572-85. PubMed ID: 27203180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 papain-like protease inhibits ISGylation of the viral nucleocapsid protein to evade host anti-viral immunity.
    Rhamadianti AF; Abe T; Tanaka T; Ono C; Katayama H; Makino Y; Deng L; Matsui C; Moriishi K; Shima F; Matsuura Y; Shoji I
    J Virol; 2024 Sep; 98(9):e0085524. PubMed ID: 39120134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro.
    Kiba Y; Tanikawa T; Kitamura M
    Biol Pharm Bull; 2024; 47(5):965-966. PubMed ID: 38763750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2.
    Smith E; Davis-Gardner ME; Garcia-Ordonez RD; Nguyen TT; Hull M; Chen E; Baillargeon P; Scampavia L; Strutzenberg T; Griffin PR; Farzan M; Spicer TP
    SLAS Discov; 2020 Dec; 25(10):1152-1161. PubMed ID: 33043784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.